Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Max Planck, Phigenix, and More

Premium

Title: RNA Sequence-specific Mediators of RNA Interference

Patent Number: 8,632,997

Filed: Oct. 4, 2010

Lead Inventor: Thomas Tuschl, Max Planck Institute


Title: dsRNA-induced Specific and Non-specific Immunity in Crustaceans and Other Invertebrates and Biodelivery Vehicles for use Therein

Patent Number: 8,633,028

Filed: July 2, 2004

Lead Inventor: Paul Gross, Medical University of South Carolina


Title: Targeting PAX2 for the Treatment of Breast Cancer

Patent Number: 8,633,149

Filed: May 24, 2011

Inventor: Donald Carlton, Phigenix


Title: siRNA Targeting Histamine Receptor H1

Patent Number: 8,633,306

Filed: Aug. 10, 2011

Lead Inventor: Anastasia Khvorova, Dharmacon (Thermo Fisher Scientific)

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.